Indication
Hypereosinophilic syndrome
Hypereosinophilic syndrome comprises a heterogeneous group of rare disorders characterized by marked, sustained overproduction of eosinophils in peripheral blood or tissues without identifiable secondary causes. Read more about Hypereosinophilic syndrome
31 drugs 29 manufacturers
Drugs that treat it
Common Hypereosinophilic syndrome therapies.
IMATINIB MESYLATE
IMATINIB MESYLATE
IMATINIB MESYLATE
IMATINIB MESYLATE
IMATINIB MESYLATE
IMKELDI (imatinib mesylate)
IMATINIB MESYLATE
IMATINIB MESYLATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHypereosinophilic syndrome comprises a heterogeneous group of rare disorders characterized by marked, sustained overproduction of eosinophils in peripheral blood or tissues without identifiable secondary causes.
The condition occurs predominantly in adults, though it can manifest at any age.
Pathophysiologically, sustained hyperactivation and degranulation of eosinophils lead to cytotoxicity, local inflammation, and progressive tissue remodeling.
Clinical manifestations vary widely according to the pattern of tissue infiltration, frequently producing multiorgan dysfunction or damage across the dermatologic, cardiac, pulmonary, gastrointestinal, and central or peripheral nervous systems.
- nih.gov
Hypereosinophilic syndrome comprises a heterogeneous group of rare disorders characterized by marked, sustained overproduction of eosinophils in peripheral blood or tissues without identifiable secondary causes The condition occurs predominantly in adults, though it can manifest at any age Clinical manifestations vary widely according to the pattern of tissue infiltration, frequently producing multiorgan dysfunction or damage across the dermatologic, cardiac, pulmonary, gastrointestinal, and cen...
- nih.gov
Hypereosinophilic syndrome comprises a heterogeneous group of rare disorders characterized by marked, sustained overproduction of eosinophils in peripheral blood or tissues without identifiable secondary causes
- merckmanuals.com
Hypereosinophilic syndrome comprises a heterogeneous group of rare disorders characterized by marked, sustained overproduction of eosinophils in peripheral blood or tissues without identifiable secondary causes
- uihc.org
The condition occurs predominantly in adults, though it can manifest at any age
- nih.gov
Pathophysiologically, sustained hyperactivation and degranulation of eosinophils lead to cytotoxicity, local inflammation, and progressive tissue remodeling
- mayoclinic.org
Pathophysiologically, sustained hyperactivation and degranulation of eosinophils lead to cytotoxicity, local inflammation, and progressive tissue remodeling Clinical manifestations vary widely according to the pattern of tissue infiltration, frequently producing multiorgan dysfunction or damage across the dermatologic, cardiac, pulmonary, gastrointestinal, and central or peripheral nervous systems
- nih.gov
Clinical manifestations vary widely according to the pattern of tissue infiltration, frequently producing multiorgan dysfunction or damage across the dermatologic, cardiac, pulmonary, gastrointestinal, and central or peripheral nervous systems
Personalize your experience
Follow Hypereosinophilic syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.